期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 25, 期 15, 页码 3005-3008出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2015.05.018
关键词
1,4-Dihydroquinolines; P-gp inhibitor; Structure-activity relationships; Substrate properties; Mdr reversal
资金
- DFG - Germany (German Research Foundation) [HI 687/6-3]
- European Union (EU) [1184256]
Multidrug resistance (mdr) is the most important problem in the therapeutical treatment of cancer. One central problem in the resistance proceeding is the expression of transmembrane efflux pumps which transport drugs out of the cells. We developed novel substituted 1,4-dihydroquinolines as inhibitors of the transmembrane efflux pump P-glycoprotein. Structure-activity relationships are discussed for this first series. Promising active inhibitors have been identified and first bioanalytical studies have been carried out to address questions of cellular toxicity, P-gp substrate as well as mdr reversal properties. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据